These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16201717)

  • 41. Further evidence for an association between the XbaI polymorphism at the apolipoprotein B locus and lipoprotein level.
    Leren TP; Berg K; Hjermann I; Leren P
    Clin Genet; 1988 Dec; 34(6):347-51. PubMed ID: 2906824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism of Trp64Arg in beta3-adrenergic receptor gene and serum LDL-cholesterol concentrations in healthy Japanese.
    Kotani K; Sakane N; Kurozawa Y; Kaetsu A; Okamoto M; Osaki Y; Kishimoto T
    Ann Clin Biochem; 2008 May; 45(Pt 3):313-5. PubMed ID: 18482921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening for the new variant of defective receptor-binding apolipoprotein B-100].
    Li Y; Feng J; Li W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1434-5. PubMed ID: 11930615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension.
    Niu W; Guo X; Su Y; Qiu C
    J Hum Hypertens; 2007 Apr; 21(4):337-9. PubMed ID: 17230232
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
    Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
    Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
    Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H; Rhyne J; Abby S; Lai YL; Jones M
    Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.
    Yoshida T; Yajima K; Hibino T; Kato K; Matsuo H; Segawa T; Watanabe S; Oguri M; Yokoi K; Nozawa Y; Kimura G; Yamada Y
    Int J Mol Med; 2007 Oct; 20(4):581-90. PubMed ID: 17786291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared.
    Henderson BG; Wenham PR; Ashby JP; Blundell G
    Clin Chem; 1997 Sep; 43(9):1630-4. PubMed ID: 9299944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia.
    Homer VM; George PM; du Toit S; Davidson JS; Wilson CJ
    Ann Neurol; 2005 Jul; 58(1):160-3. PubMed ID: 15984016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Familial apolipoprotein B-100 defect, a newly discovered lipid metabolism disorder].
    Ceska R
    Cas Lek Cesk; 1994 Nov; 133(22):686-9. PubMed ID: 7805094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial defective apolipoprotein B-100: detection and haplotype analysis of the Arg(3500)-->Gln mutation in hyperlipidemic Chinese.
    Teng YN; Pan JP; Chou SC; Tai DY; Lee-Chen GJ
    Atherosclerosis; 2000 Oct; 152(2):385-90. PubMed ID: 10998466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects.
    Horvath A; Savov A; Kirov S; Karshelova E; Paskaleva I; Goudev A; Ganev V
    J Med Genet; 2001 Aug; 38(8):536-40. PubMed ID: 11494965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.